Search

Search Constraints

You searched for: Author/Creator Israeli, E

Search Results

2. P571 Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study. (25th January 2019)

3. P747 A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database. (25th January 2019)

4. P785 The prevalence of inflammatory bowel disease doubled in the last decade in Israel: an epiIIRN national population-based study. (25th January 2019)

6. Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial. (14th July 2015)

7. P275 Course of COVID-19 in patients with Inflammatory Bowel Diseases treated with biologics: the Israeli experience. (27th May 2021)